Results 81 to 90 of about 1,907,587 (220)

Potential entry pathways for 25 vector‐borne disease agents

open access: yesEFSA Journal, Volume 24, Issue 5, May 2026.
Abstract This Scientific Report identifies the potential entry pathways for 25 selected vector‐borne diseases (VBDs) into currently free EU Member States. The diseases comprise 12 listed under the Animal Health Law (AHL) and 13 non‐listed diseases, selected using predefined eligibility criteria.
European Food Safety Authority (EFSA)   +7 more
wiley   +1 more source

Knowledge mapping of risk mitigation measures against vector‐borne diseases

open access: yesEFSA Journal, Volume 24, Issue 5, May 2026.
Abstract A comprehensive synthesis of current evidence on surveillance, prevention and control measures for 25 selected vector‐borne diseases (VBDs) affecting animals in the EU is presented here. The assessment integrates evidence from systematic literature reviews, modelling studies, field investigations and expert judgement.
European Food Safety Authority (EFSA)   +8 more
wiley   +1 more source

Rift Valley Fever in Small Ruminants, Senegal, 2003

open access: yesEmerging Infectious Diseases, 2005
During the 2003 rainy season, the clinical and serologic incidence of Rift Valley fever was assessed in small ruminant herds living around temporary ponds located in the semi-arid region of the Ferlo, Senegal. No outbreak was detected by the surveillance
Véronique Chevalier   +5 more
doaj   +1 more source

Identification and mapping of potential and highly likely vectors for selected vector‐borne diseases in the EU and neighbouring countries

open access: yesEFSA Journal, Volume 24, Issue 5, May 2026.
Abstract This report addresses Term of Reference 1.2 by providing a comprehensive knowledge‐mapping of arthropod vector species competent to transmit selected vector‐borne diseases (VBDs) including VBDs listed under Regulation (EU) 2016/429 and Regulation (EU) 2020/687, as well as additional non‐listed pathogens with potential epidemiological relevance.
European Food Safety Authority (EFSA)   +7 more
wiley   +1 more source

Uukuniemi Phlebovirus assembly and secretion leave a functional imprint on the Virion Glycome [PDF]

open access: yes, 2014
Uukuniemi virus (UUKV) is a model system for investigating the genus Phlebovirus of the Bunyaviridae. We report the UUKV glycome, revealing differential processing of the Gn and Gc virion glycoproteins.
Scrivens, JH   +23 more
core   +1 more source

Rift Valley Fever in Chad

open access: yesEmerging Infectious Diseases, 2004
To evaluate the importance of human exposure to Rift Valley fever virus in Chad, investigations were carried out to determine specific antibody prevalence in domestic ruminants during the 2002 rainy season. Results highlighted recent, substantial, active
David Ringot   +4 more
doaj   +1 more source

143 Rift Valley fever virus

open access: yesJAIDS Journal of Acquired Immune Deficiency Syndromes, 2014
The capacity of Rift Valley fever virus (RVFV) to spread into new territories by crossing significant natural geographic barriers, re-emerge in endemic regions after long periods of silence to cause large outbreaks in human and animal populations constitute a formidable challenge for public and veterinary health authorities as well as for scientific ...
openaire   +2 more sources

Novel approaches to develop Rift Valley fever vaccines

open access: yesFrontiers in Cellular and Infection Microbiology, 2012
Rift Valley fever (RVF) is endemic to sub-Saharan Africa, and has spread into Madagascar, Egypt, Saudi Arabia and Yemen. Rift Valley fever virus (RVFV) of the family Bunyaviridae, genus Phlebovirus causes hemorrhagic fever, neurological disorders or ...
Sabarish V. Indran, Tetsuro eIkegami
doaj   +1 more source

Animal models of Rift Valley fever virus infection

open access: yesVirus Research, 2012
Emerging and naturally occurring infectious diseases from bacterial and viral sources are constantly threatening humans and livestock. Recently, a variety of infectious diseases have emerged into previously disease-free areas, resulting in new epidemics. Consequently, governmental agencies and researchers in the area of biomedical research have started
Ted M, Ross   +4 more
openaire   +2 more sources

In vitro and in vivo efficacy of a Rift Valley fever virus vaccine based on pseudovirus

open access: yesHuman Vaccines & Immunotherapeutics, 2019
Rift Valley fever virus (RVFV), a recognized category A priority pathogen, causes large outbreaks of Rift Valley fever with some fatalities in humans in humans and huge economic losses in livestock.
Jian Ma   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy